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Thursday, March 1
10:30 - 11:30 Studio 2012 
organised by Siemens Healthcare
SY 1 
3D tomosynthesis: opportunities for breast cancer 
imaging 
Moderator: 
T. Mertelmeier; Erlangen/DE 
Introduction
T. Mertelmeier; Erlangen/DE 
3D breast tomosynthesis: a problem solver for difficult cases in 
clinical routine
J. Barkhausen; Lübeck/DE 
Breast tomosynthesis: a feasible breast cancer screening modality?
S. Zackrisson; Malmö/SE 
3D breast tomosynthesis and contrast enhanced dual energy:
a prototype report
T.H. Helbich; Vienna/AT 
Panel discussion 
12:30 - 13:30 Room G/H 
organised by SuperSonic Imagine
SY 2
Programme not available by date of print
12:00 - 13:30 Studio 2012 
organised by Siemens Healthcare
SY 3 
Imaging for breast cancer therapy planning, 
execution and control 
Moderator: 
J. Barkhausen; Lübeck/DE 
Introduction
J. Barkhausen; Lübeck/DE 
3D breast ultrasound: a poor man’s MRI? 
M.J.C.M. Rutten; ‘s-Hertogenbosch/NL 
Automated 3D breast ultrasound is a new technique, which scans the breast au-
tomatically and almost entirely. Data sets can be stored and are available for 3D 
cross correlating review. This new technique eliminates significantly the subjectiv-
ity of conventional ultrasound, disconnects US data acquisition and assessment, 
facilitates the possibility of double reading, presurgical workup planning, review of 
follow-up studies and the application of computer aided detection. Automated 3D 
ultrasound can be implemented in the clinical radiological setting and possibly in 
a personalized screening program for breast cancer. 
Learning Objectives:
1.   To become familiar with the 3D breast ultrasound technique and scanning 
protocols.
2.   To comprehend the indications and limitations of 3D breast ultrasound.
3.   To become familiar with the diagnostic accuracy of 3D breast ultrasound and 
to appreciate the potential added value for breast cancer screening.
4.   To highlight novel developments in 3D breast US, such as computer aided 
detection.
Potential role of digital breast tomosynthesis (DBT) in breast cancer 
diagnosis 
N. Uchiyama; Tokyo/JP 
In this lecture, the author addresses the potential role of DBT in comparison with 
other diagnostic modalities in breast cancer including technical principles and 
clinical experiences. In comparison with 2D mammograms, DBT is better able 
to distinguish a lesion from overlapping breast tissue and to improve detection 
performance especially of masses and makes it possible to clarify the location or 
distribution of microcalcifications. In comparison with CE MRI, the diagnostic per-
formance of DBT is comparable or better in some cases. CE MRI has an advantage 
in detecting cancerous lesions and extensive intraductal component or daughter 
lesions associated with the main cancerous lesions. However, by CE MRI, the 
differentiation between a small cancerous or benign lesion is sometimes difficult. 
On the other hand, the pixel size of DBT is much smaller than MRI and has an 
advantage regarding the morphological diagnostic approach. In comparison with 
US, the diagnostic performance of DBT is comparable in detecting mass lesions. 
In addition, DBT has advantages in detecting the lesions with microcalcifications, 
a large area, or multi-focal lesions in comparison with US. 
Learning Objectives:
1.   To understand image acquisition and image reconstruction principles of DBT
2.   To understand the advantages and disadvantages of DBT compared to other 
diagnostic modalities
3.   To understand the findings of DBT with reference to pathological diagnosis 
and 2D mammograms
Impact of imaging on staging, planning and treatment delivery in 
curative breast cancer radiotherapy 
S. Bodis; Aarau/CH 
High-precision radiotherapy (RT) and vigorous QA are mandatory for curative breast 
cancer (BC) RT concepts. Modern imaging is mandatory both for timely staging, 
RT-planning and guidance of RT-delivery. Available three-dimensional diagnostic 
tools for local and loco-regional breast imaging are e.g. CT, MRI and PET. Fusion 
of all relevant diagnostic images with RT-planning images should be a routine 
process. There is room for improvements on all levels. In general, diagnostic and 
therapeutic radiation disciplines need to be better coordinated. Specifically, imag-
ing processing for RT-planning and RT-delivery has to be more users friendly and 
robust. Streamlining und simplifying workflow is one important task for the future. 
Promising RT-planning tools from diagnostic 3D data sets (e.g. image guided breast 
biopsy, digital tomosynthesis, breast MRI and regional CT-PET) need to be tailored 
to the needs of radiation oncology planning (identical patient positioning for diagno-
sis and therapy, data processing like image fusion, data transfer and data storage). 
Radiation oncologists are lost in a swamp of diagnostic images which cannot be 
further processed, stand alone software and hardware from competing providers. 
Clinical radiation oncology study protocols and radiation oncology standards also 
need better description and definition of the most appropriate imaging methods 
for defined BC RT-concepts. 
Learning Objectives:
1.   Demonstrate and discuss workflow for RT-planning and RT-delivery with 
modern imaging
2.   Future developments of imaging in curative breast cancer RT
3.   Future opportunities for the link of diagnostic radiology and therapeutic radio-
therapy
From control to prediction, moving forward in the field of 
neoadjuvant chemotherapy 
R.M. Mann; Nijmegen/NL 
While the use of neoadjuvant chemotherapy (NAC) historically was a last resort, 
it has now gained a place in the treatment of resectable and even relatively small 
breast cancers. Evaluation of response to NAC is a radiological challenge that is 
best tackled by MRI. Since NAC is by nature toxic, early proof of curative potential 
is essential to prevent unnecessary harm to patients. Currently available tools 
however still focus on changes in size of the tumor and therapy is only altered in 
clear non-responders. Application of novel and improved MRI techniques such as 
farmacokinetic modeling, diffusion weighted imaging and MR spectroscopy, as 
well as PEM may allow earlier identification of responders and non-responders 
and even predict eventual response prior to the start of therapy. However, none of 
these modalities is by itself specific enough to alter current practices. It thus seems 
that we will need to rely on sophisticated computer algorithms for the combination 
of all available evidence in order to improve patient care. 
Learning Objectives:
1.   To define the current position of radiological imaging in the evaluation of 
patients treated with NAC.
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2.   To understand the nature of new techniques for the evaluation of NAC.
3.   To be able to give a global prediction of the probable response of a tumor to 
NAC.
Panel discussion 
14:30 - 16:00 Studio 2012
jointly organised by Siemens Healthcare and Bayer 
Healthcare
SY 4 
Programme not available by date of print 
Friday, March 2
12:30 - 13:30 Room D1 
organised by Bayer Healthcare
SY 5 
Leading the way in contrast-enhanced MR imaging 
Moderator: 
F. Sardanelli; San Donato/IT 
Choice of contrast in CNS MRI: what is the impact?
N. Anzalone; Milan/IT 
More than 10 years of experience with Gadovist®
F. Sardanelli; San Donato/IT 
VALUE of Primovist® MRI vs CE-MRI and MDCT for staging of 
patients with liver metastases
C.J. Zech; Munich/DE 
12:30 - 13:30 Room F2 
organised by GE Healthcare
SY 6 
High-field MRI in a new light 
Moderator: 
A. van der Lugt; Rotterdam/NL 
Humanising radiology
J. Coumans; Waukesha, WI/US 
3T MRI: new trends in cerebral vascular imaging
J. Hodel; Paris/FR 
PET/MR vs PET/CT: the clinical reality check starts
G.K. von Schulthess; Zurich/CH 
12:30 - 13:30 Room G/H
organised by Bracco
SY 7 
Strategies for radiation dose reduction in contrast-
enhanced CT 
Moderator: 
C. Catalano; Rome/IT 
How to marry scanner and contrast variables to maximise radiation 
dose reduction
M. Prokop; Nijmegen/NL 
Coronary CTA and beyond: new evidence and recommendations
H.-C. Becker; Munich/DE 
Protocols for body CT: tips and tricks
A.J. Aschoff; Kempten/DE 
Interactive discussion 
12:30 - 13:30 Room I/K
organised by Philips Healthcare
SY 8 
Programme not available by date of print 
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Why not having both with cardiac hybrid imaging?
O. Gämperli; Zurich/CH 
Purpose: Computed tomography coronary angiography (CTCA) and myo-
cardial perfusion imaging techniques (single photon emission computed 
tomography, SPECT, or positron emission tomography, PET) are established 
non-invasive modalities for the diagnosis of coronary artery disease (CAD). 
Material and Method: Cardiac hybrid imaging consists of the combination 
(or ‚fusion‘) of both modalities and allows obtaining complementary morpho-
logical (coronary anatomy, stenoses) and functional (myocardial perfusion) 
information in a single setting. However, hybrid cardiac imaging has also 
generated controversy with regard to which patients should undergo such 
integrated examinations for clinical effectiveness and minimization of costs 
and radiation dose. The feasibility and clinical value of hybrid imaging has 
been documented in small cohort studies and selected series of patients. 
Results: Hybrid imaging appears to offer superior diagnostic and prognostic informa-
tion compared with stand-alone or side-by-side interpretation of data sets. Particu-
larly in patients with multivessel disease, the hybrid approach allows identification of 
flow-limiting coronary lesions and thereby provides useful information for the plan-
ning of revascularization procedures. Furthermore, integration of the detailed ana-
tomical information from CTCA with the high molecular sensitivity of SPECT and PET 
may be useful to evaluate targeted molecular and cellular abnormalities in the future. 
Conclusion: While currently still restricted to specialized cardiac centres, the ongoing 
efforts to reduce radiation exposure and the increasing clinical interest will further 
pave the way for an increasing use of cardiac hybrid imaging in clinical practice. 
Questions and answers
S. Plein; Leeds/UK 
12:30 - 13:30 Room F1
organised by Hitachi
SY 11 
Programme not available by date of print 
12:30 - 13:30 Room F2
organised by Philips Healthcare
SY 12 
Programme not available by date of print 
12:30 - 13:30 Room I/K
organised by Bracco
SY 13 
Programme not available by date of print 
12:30 - 13:30 Room L/M 
organised by Philips Healthcare
SY 14 
Advances in radiology ultrasound using the  
iU22 xMatrix 
Moderator: 
E. Leen; London/UK 
xMatrix, a new diagnostic tool for abdominal ultrasound
D.A. Clevert; Munich/DE 
Advancements in musculoskeletal ultrasound
C. Martinoli; Genoa/IT 
New advances in liver elastography
O. Kolokythas; Seattle, WA/US 
Saturday, March 3
12:30 - 13:30 Room D1 
jointly organised by Siemens Healthcare and
Bayer Healthcare
SY 9 
Synergies in CT - for better patient care 
Moderator: 
J.E. Wildberger; Maastricht/NL 
Programme not available by date of print 
12:30 - 13:30 Room E1 
organised by Guerbet
SY 10 
Vessel and muscle in coronary heart disease 
Moderator: 
S. Plein; Leeds/UK 
Introduction
S. Plein; Leeds/UK 
Updated developments in coronary MSCT in patients with atrial fibrillation
M. Dewey; Berlin/DE 
In patients with atrial fibrillation coronary CT angiography is not reliably performed 
with high nondiagnostic rates in the per-patient analyses. Using 320-row volume CT 
one can scan the entire heart in a single rotation during just one heart beat (Dewey 
et al. Circulation 2009). This has great potential to enable reliable imaging also in 
patients with atrial fibrillation who are often sent for invasive angiography simply to 
rule out coronary artery disease. The hypothesis of the present trial will thus be that 
coronary CT angiography using 320 simultaneous detector rows using iobitridol 350 
as the contrast agent results in high accuracy for detection of coronary stenoses 
in comparison to conventional coronary angiography in all patients (head-to-head 
comparison). Also interobserver variability, image quality, contrast agent amount, and 
radiation exposure required for volume CT and conventional coronary angiography 
will be intraindividually compared in all patients as the primary secondary objectives. 
Detection of occult myocardial infarcts and coronary stenosis in 
asymptomatic diabetic patients
T.-H. Lim; Seoul/KR 
Cardiac computed tomography angiography (CCTA) has emerged as a valid alterna-
tive imaging modality for the evaluation of patients with known or occult CAD. With 
the advent of MDCT technology, CCTA has the potential to provide comprehensive 
information regarding the location, severity, and characteristics of atherosclerotic 
plaque. Recently, CCTA has been suggested as a potential tool for providing a 
better insight about the occult CAD in asymptomatic individuals including asymp-
tomatic patients with type 2 diabetes. Cardiac magnetic resonance (CMR) imaging 
can detect and characterize myocardial scar that is missed by ECG, conventional 
wall motion, or nuclear scintigraphic techniques but is associated with important 
cardiac events, including death and recurrent myocardial infarction. Furthermore, 
CMR imaging can characterize occult myocardial scar on delay-enhanced MRI 
(DE-MRI) in diabetic patients without clinical evidence of myocardial infarction, 
and this occult myocardial scar showed strong association with major adverse 
cardiac events (MACE) and mortality hazards that is incremental to clinical, ECG, 
and left ventricular function combined. The ACCREDIT study (Assessment with 
Cardiac Computed Tomography Angiography and Magnetic Resonance Imaging 
in Patients with with Type 2 Diabetes for Detection of Unrecognized Myocardial 
Scar in Subclinical Coronary Atheroslerosis) were planned and performed for two 
purposes; 1. to prospectively investigate the prevalence and predictors of occult 
myocardial scar on CMR imaging in subclinical atherosclerosis with type 2 Diabe-
tes on CCTA or with traditional risk factors for CAD, and 2. to test the hypothesis 
whether subclinical coronary atherosclerosis on CCTA is associated with and 
myocardial scar on DE-MRI to provide strong prognostic value in asymptomatic 
patients with type 2 diabetes. The preliminary results of the ACCREDIT study will 
be provided in this lecture. 
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14:00 - 15:30 Room D1 
organised by Siemens Healthcare
SY 18 
Creating the future of MRI 
Moderator: 
C.D. Claussen; Tübingen/DE 
Welcome creating the future of MRI
C. Zindel; Erlangen/DE 
3T MRI - between a luxury good and clinical necessity
A. McKenna-Küttner; Frankfurt/DE 
How to address workflow challenges in a broad spectrum MRI-
service: first experiences with Dot
C. Bremer; Münster/DE 
Biograph mMR - clinical reality of simultaneous MR-PET and future 
realm of possibilities
C.D. Claussen; Tübingen/DE 
14:00 - 15:30 Room E1
organised by Toshiba
SY 19 
Programme not available by date of print 
14:00 - 15:30 Room N/O 
organised by GE Healthcare
SY 20 
From in-vivo to in-vitro, enabling personalised 
cancer care 
Moderator: 
R.C. Sigal; Velizy/FR 
Is there any advantage of volume navigation and needle tracking 
techniques in the management of oncology patients?
T. Albrecht; Berlin/DE 
MRgFUS: a non-invasive approach to thermoablation
A. Beck; Berlin/DE 
The clinical role of molecular breast imaging
E. Even-Sapir Weizer; Tel Aviv/IL 
12:30 - 13:30 Room N/O 
organised by Philips Healthcare
SY 15 
Shaping the future of breast cancer screening 
Moderators: 
M. Danielsson; Solna/SE 
H. Ringertz; Linköping/SE 
Single-shot spectral mammography in clinical practice
M.G. Wallis; Cambridge/UK 
A challenge within mammography is to improve cancer detection while at the same 
time reducing the rate of unnecessary recalls. In CT it is today common practice 
to use dual energy methods to discriminate between different tissues. Phantom 
work using a new photon counting spectral detector from Philips suggests it might 
also be possible to use similar methods in mammography. One example presented 
here is to assess the water content of circular lesions, thereby adding supportive 
information to radiologists when making a decision about recall or not. A study 
aiming at providing a firm scientific base to develop these ideas is now ongoing 
and the information obtained will be used to optimize the detector software and 
determine the spectral fingerprint of cysts. 
Breast density measurement - risk assessment in screening
S. Molloi; Irvine, CA/US 
It is known that dense breasts imply a higher risk for developing breast cancer. 
Work is ongoing to find objective ways of measuring breast density, and in the future 
tie that to risk assessment. The vision is that all women shall have breast density 
measurements done at screening and based on that the radiologists can decide 
who is at risk and needs shorter screening intervals and also possible additional 
examinations with for example ultrasound. Dual energy mammography was used 
to measure breast density. In this study postmortem breasts were imaged and a 
comparison was made between dual energy mammography, MRI and CT, with 
chemical decomposition as gold standard. Philips’ photon counting detector has 
the ability to distinguish high energy photons from photons with low energy and a 
study has been conducted looking at the potential for spectral mammography to 
accurately measure breast density without the additional radiation dose. 
Benefits of dose reduction in mammography
E. Pisano; Charleston, SC/US 
Breast cancer screening is a well-established method for reducing mortality in 
women, because cancers can be detected at an early stage with a far better 
prognosis. For a radiologist the image quality is the most important aspect and 
the determining factor for finding breast cancer at an early stage. However, breast 
tissue is sensitive to radiation and the risk of x-ray induced cancer is relative to 
lifetime exposure, therefore the ALARA principle is a regulatory requirement for all 
radiation safety programs. A non-inferiority study has been conducted comparing 
Philips MicroDose to a predicate device showing that dose reduction does not 
necessarily imply compromising image quality. 
13:30 - 17:30 Studio 2012
organised by Bracco
SY 16 
Programme not available by date of print 
14:00 - 15:30 Room C
organised by Hologic
SY 17 
Programme not available by date of print 
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replace conventional XRay exams by CT exams in certain indications. In summary, 
Veo enabled to reach dose reduction of 70-85% in paediatric examinations while 
maintaining and even improving image quality, depending on the type of exam. 
Dose reduction up to 90% and more was reached providing diagnostic quality 
images. This is of major importance in paediatric population which is known to be 
highly sensitive to radiation dose. 
New advances in cardiovascular CT to lower dose and improve diagnosis
G. Pontone; Milan/IT 
The anatomical evaluation of the coronary arteries, the clinical indication for 
revascularization procedure and follow-up of patients has always been prerogative 
of invasive coronary angiography. However this technique has several disadvan-
tages. First, it is invasive and associated with a not negligible incidence of adverse 
events. Second, it is expensive and last the information obtained via catheter-based 
coronary angiography pertains to the coronary arterial lumen alone. The introduc-
tion of multidetector computed tomography scanner associated with high-speed 
and ECG gated X-ray tube allowed an increase in spatial and temporal resolution 
such as to consider this technology a valuable alternative to the invasive coronary 
angiography. More recently, the use of low-dose technologies, such as SnapShot 
Pulse acquisition mode or ASiR (Adaptive Statistical Iterative Reconstruction) and 
High Definition scanner (Discovery CT750 HD, GE Healthcare) should allow to 
enlarge the indication of this test to middle age patients and to high risk patient. 
The aim of this lecture is to describe technical background, clinical applications of 
Cardiac CT and to present the new advances in Cardiovascular CT to lower dose 
and improve diagnosis. 
Questions and answers
12:30 - 13:30 Room E1
organised by Toshiba
SY 22 
Programme not available by date of print 
12:30 - 13:30 Room G/H
organised by Philips Healthcare
SY 23 
Programme not available by date of print 
12:30 - 13:30 Room I/K
organised by Bracco
SY 24 
Dynamic contrast enhanced ultrasound: an 
established radiation-free option for abdominal 
radiology 
Moderator: 
L. Solbiati; Busto Arsizio/IT 
Introduction: 2011 and 2012, European and worldwide update of 
recommendations for CEUS
L. Solbiati; Busto Arsizio/IT 
CEUS, a solution to reduce radiation exposure in abdominal imaging
P.S. Sidhu; London/UK 
Vuebox(TM) a new quantification software tool dedicated to CEUS
F. Tranquart; Geneva/CH 
Advances in interventional radiology with xMatrix CEUS and fusion 
imaging
E. Leen; London/UK 
Sunday, March 4
12:30 - 13:30 Room C 
organised by GE Healthcare
SY 21 
New paradigm in CT imaging capabilities and 
patient care 
Moderator: 
J. de Mey; Brussels/BE 
Introduction
J. de Mey; Brussels/BE 
Preserving diagnostic image quality with new CT reconstruction 
techniques and low concentration Iso-osmolar contrast media
J.-L. Sablayrolles; St. Denis/FR 
Purpose: The purpose of this study was to investigate and demonstrate 
that with image reconstruction techniques such as ASiR® and Veo®, diag-
nostic image quality is maintained in patients scanned at lower kVp and in-
jected with low concentration Visipaque® compared to Iomeron® 400mgI/ml. 
Method and Materials: Visipaque® 270 or 320mgI/ml (GE Healthcare) was injected 
at 3.5ml/s into a semianthropomorphic dynamic liver phantom (QRM, Germany) and 
CT scans were performed using a HD 750 CT scanner (GE Healthcare) at 80, 100 or 
120 kVp at fixed mA (10 - 500 mA) to obtain arterial (35s), arterial / portal (45s) and 
portal (70s) phase data. Similarly, abdominal CT was performed on patients after in-
jection of Visipaque® 270 or 320mgI/ml or Iomeron® 400mgI/ml (2cc/kg) at 3.5ml/s. 
CT scans were performed using an HD750 CT at 80, 100 and 120kVp to obtain 
arterial phase (25-35s) and portal phase (65-75s) data. Acquisition parameters were 
set according to patient’s BMI. In both settings, projection data was reconstructed 
with FBP (standard) and two types of iterative reconstruction ASIR®-50% and Veo®. 
Results: In the dynamic phantom, marked stepwise reductions in noise were ob-
served with both 120 and 100kVp scans after ASIR®-50% and Veo® reconstruction 
compared to FBP after injection of Visipaque at 270 or 320mgI/ml. By contrast, 
marked increases in “venous” enhancement was observed in 100kVp scans after 
injection of Visipaque® 270mgI/ml compared to 120kVp scans after injection of 
Visipaque® 320mgI/ml. Clinical results matched the observations in the dynamic 
phantom. In patients, 100 kVp combined with advanced reconstruction and Visi-
paque® 270 mgI/ml gave better contrast than 120 kVp with FBP and Visipaque® 
320 mgI/ml. Importantly, contrast enhancement with Iomeron® 400mgI/ml was not 
superior to Visipaque® 320mgI/ml when used in conjuction with ASIR. Indeed, ASiR 
and Veo reconstructions improved overall image quality of parenchyma, edges and 
interfaces and vascular structures after reduction in kVp and iodine concentration. 
Conclusion: These data demonstrate that advanced reconstruction with ASIR® or 
Veo® in combination with low kVp (80 or 100) and low concentration Visipaque® 
(270 or 320mgI/ml) delivers equivalent or better contrast enhancement and im-
proved diagnostic images compared to Iomeron® 400mgI/ml without impairing 
noise. Such improved contrast enhancement at low iodine concentrations and/or 
lower radiation dose represents a clear opportunity to improve patient care in CT. 
Dose in paediatric imaging: how low can we go?
C. Ernst; Brussels/BE 
Radiation dose is a major concern in computed tomography (CT) imaging, especially 
for sensitive organs or populations. A recent survey highlighted that only 43% of 
facilities adjusted CT techniques for children, whilst another survey found that 80% 
of CT studies in children were not managed by paediatric radiologists. In recent 
years Iterative reconstruction techniques have enabled a substantial reduction of 
radiation dose during CT scans. Several users reported a dose reduction that could 
reach 50%, in some specific cases even 65 %, in pediatric imaging with ASiR itera-
tive reconstruction, which models noise root cause in the reconstruction process. 
New techniques allow to model the image chain in the reconstruction process, 
leading to an increased spatial resolution at lower dose. GE Healthcare made 
recently this techniques available in clinical practice with the Veo product introduc-
tion. A series of pediatric patients presenting recurrent diseases (cystic fibrosis or 
lymphoma) were scanned and reconstructed with Veo. A dose reduction of 70% 
was noticed compared to FBP reconstruction and depending on the type of exam 
even a dose reduction of 85% was obtained without image quality loss. On some 
CT thorax examinations diagnostic quality images could be obtained with a dose 
of 0.05 mSv wich, after further investigation, could provide new opportunities to 
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12:30 - 13:30 Room L/M
organised by Siemens Healthcare
SY 25 
Pioneering the future of ultrasound 
Programme not available by date of print 
12:30 - 13:30 Room N/O
organised by Philips Healthcare
SY 26 
Programme not available by date of print
Saturday, March 3
10:00 - 11:00 Room 13 
Mini Satellite Symposium organised by im3D
MSY 1 
Enhancing diagnosis in CT-colonography: CAD in 
clinical practice, screening and training 
Moderator: 
A. Laghi; Latina/IT 
CAD-radiologist interaction in clinical diagnosis: lessons from the 
CADIMPACT trial
D. Regge; Turin/IT 
What we know about training radiologists: current status and future 
directions
P. Lefere; Roeselare/BE 
Mass screening with CT-colonography: towards a patient friendly, 
computer-assisted examination
G. Iussich; Turin/IT 
Final discussion 
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